BOPA 2023 | Community pharmacies improve engagement in screening programs

Shereen El Nabhani-Gebara, PharmD, Kingston University, London, UK, discusses the need for novel approaches that will improve engagement in cancer screening programs, with a focus on bowel cancer screening. The uptake for bowel cancer screening is relatively low in certain areas with higher deprivation and ethnic diversity, and Dr El Nabhani-Gebara discusses the potential reasons behind this. She then reports on a pilot study looking at how community pharmacies can support screening programs, in which people could access information about bowel cancer in their preferred language by scanning a QR code. The trial showed an improvement in knowledge, perception, and intent to engage in the cancer screening program. This interview took place at the 26th Annual British Oncology Pharmacy Association (BOPA) Symposium in Newport, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.